☆ 4.6 Article

Antigen rapid diagnostic test monitoring for SARS-CoV-2 in asymptomatic and fully vaccinated cancer patients: Is it cost-effective?

CANCER MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic

Seyed Alireza Javadinia et al.

Summary: This study assessed the seroprevalence of SARS-CoV-2 IgG antibody in a cancer population referred for vaccination, finding that some cancer patients already had immunity to the virus prior to vaccination. The analysis showed that females and patients with a prior history of COVID-19 were more likely to have immunity before vaccination.

CANCER INVESTIGATION (2022)

添加到收藏夹

Article Oncology

Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy

Mona Ariamanesh et al.

Summary: The study confirmed the safety and short-term efficacy of the inactivated SARS-CoV-2 vaccine in cancer patients, with an overall seroconversion rate of 86.9%. However, the conversion rate was lower in older age groups, those with hematological malignancies, and recipients of chemotherapy.

CANCER INVESTIGATION (2022)

添加到收藏夹

Article Oncology

Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients

Pierre Heudel et al.

Summary: This study investigated the impact of SARS-COV-2 vaccination on the risk of developing COVID-19 in cancer patients from a comprehensive cancer center. The results showed that vaccination played a positive role in reducing the risk of COVID-19 infection among cancer patients.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Oncology

Original Research Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study

Maximilian J. Mair et al.

Summary: This study demonstrates improved antibody levels in patients with cancer after the third vaccination dose with an acceptable side-effect profile. However, lower antibody levels compared to controls highlight the need for further follow-up studies and dedicated trials.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Oncology

Safety of COVID-19 Vaccine in Patients with Cancer in a High-Volume Comprehensive Cancer Center

Antonella Brunello et al.

Summary: This study analyzes adverse events in 5297 cancer patients undergoing anti-cancer treatment who were vaccinated with the Pfizer-BioNTech COVID-19 vaccine. The results show that 8 adverse drug reactions were reported, with one being severe and seven being non-severe. The non-severe reactions resolved within 48 hours. This is the largest study to date on the safety of vaccination in cancer patients.

ONCOLOGIST (2022)

添加到收藏夹

Article Medicine, General & Internal

Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology

Mario Caccese et al.

Summary: This study investigated the impact of the COVID-19 pandemic on cancer patients, focusing on measures to reduce SARS-CoV-2 infection and the vaccination campaign. The survey results showed that most patients appreciated the implemented measures, including the use of telemedicine. After receiving the Pfizer-BioNTech COVID-19 vaccine, nearly all patients were satisfied with the vaccination campaign, and there were no reports of serious adverse events. This information is crucial for the reorganization of healthcare systems and improvement of cancer care.

PATIENT PREFERENCE AND ADHERENCE (2022)

添加到收藏夹

Article Oncology

Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer A US Nationwide Veterans Affairs Study

Julie Tsu-Yu Wu et al.

Summary: This study investigated the impact of COVID-19 vaccination on infection rates in cancer patients, finding a lower infection rate post vaccination. Some immunosuppressed subgroups may still face early COVID-19 risk, suggesting additional risk reduction strategies such as serologic testing and a third vaccine dose should be considered.

JAMA ONCOLOGY (2022)

添加到收藏夹

Review Oncology

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

Annika Fendler et al.

Summary: The efficacy and immunogenicity of COVID-19 vaccines in cancer patients are uncertain due to their exclusion from pivotal clinical trials. In this Review, the current knowledge on vaccine efficacy and immune responses in cancer patients is summarized, highlighting key factors that may affect vaccine efficacy in this population.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?

Maryam Joudi et al.

Summary: This multi-institutional cohort study found that breast cancer patients who received inactivated SARS-CoV-2 vaccine (BBIBP-CorV) had high levels of anti-spike IgG and anti-RBD IgG, and a very low incidence of COVID-19 infection after vaccination, indicating that the vaccine is well-tolerated and effective.

FRONTIERS IN ENDOCRINOLOGY (2022)

添加到收藏夹

Review Endocrinology & Metabolism

COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety

Seyed Alireza Javadinia et al.

Summary: This paper assessed the efficacy and safety of COVID-19 vaccines in cancer patients through a systematic review and meta-analysis. The results showed that the overall seroconversion rates after receiving a second dose of COVID-19 vaccine were 88% for patients with solid tumors and 70% for patients with hematologic malignancies. Therefore, it can be concluded that COVID-19 vaccination in patients with active malignancies is highly effective, safe, and well-tolerated.

FRONTIERS IN ENDOCRINOLOGY (2022)

添加到收藏夹

Article Oncology

Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida

Anna R. Giuliano et al.

Summary: This cohort study found that the mRNA-1273 SARS-CoV-2 vaccine induced variable antibody responses that differed by cancer diagnosis and treatment received. These findings suggest that patients with hematologic cancer and those who are receiving immunosuppressive treatments may need additional vaccination doses.

JAMA ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients

Michel Obeid et al.

Summary: After vaccination with mRNA vaccines, the neutralizing antibody responses in immunocompromised patients and healthy controls have shown a decline at 6 months. These findings may provide insights for the development of optimal booster vaccination schedules, especially for immunocompromised patients.

JAMA ONCOLOGY (2022)

添加到收藏夹

Letter Oncology

Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix

Anna M. Di Giacomo et al.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Routine COVID-19 testing may not be necessary for most cancer patients

Ali Motlagh et al.

Summary: The necessity of routine COVID-19 testing for cancer patients is debated. The study results showed that while some cancer patients tested positive in routine screenings, the overall positivity rate was low. Comorbidities and age could be factors influencing test results.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Oncology

Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study

Valentina Guarneri et al.

Summary: The study showed that patients with cancer who contract COVID-19 have higher hospitalization and mortality rates. Factors such as age, comorbidities, and disease severity are significantly correlated with the risk of death.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Review Oncology

Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review

Deniz C. Guven et al.

Summary: In summary, cancer patients, especially those with hematologic malignancies and undergoing active treatment, had significantly lower seroconversion rates after COVID-19 vaccination. Further research is urgently needed to explore approaches to improve vaccine efficacy and identify novel treatment options for these patients.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Letter Oncology

Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients

P. Heudel et al.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Letter Oncology

Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment

Noa Eliakim-Raz et al.

JAMA ONCOLOGY (2021)

添加到收藏夹

Article Oncology

COVID-19 in Cancer and Non-cancer Patients

Farzad Taghizadeh-Hesary et al.

Summary: The study compared the outcomes of cancer patients and non-cancer patients infected with COVID-19, finding that cancer patients had a higher rate of COVID-19-induced mortality and mechanical ventilation.

INTERNATIONAL JOURNAL OF CANCER MANAGEMENT (2021)

添加到收藏夹

Article Oncology

COVID-19 in cancer patients may be presented by atypical symptoms and higher mortality rate, a case-controlled study from Iran

Soodabeh Shahidsales et al.

Summary: The study compared outcomes of cancer patients admitted due to COVID-19 with COVID-19 infected patients without cancer history. It found that cancer patients had significantly higher mortality rates and may present with atypical symptoms, putting them at higher risk of mortality independent of other factors.

CANCER REPORTS (2021)

添加到收藏夹

Article Oncology

High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR

Souad Assaad et al.

EUROPEAN JOURNAL OF CANCER (2020)

添加到收藏夹

Article Oncology

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lievre et al.

EUROPEAN JOURNAL OF CANCER (2020)

添加到收藏夹

Review Oncology

A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19

Emre Yekeduz et al.

EUROPEAN JOURNAL OF CANCER (2020)

添加到收藏夹

Article Oncology

SARS-CoV-2 infections in cancer outpatients-Most infected patients are asymptomatic carriers without impact on chemotherapy

Louisa Hempel et al.

CANCER MEDICINE (2020)

添加到收藏夹

Letter Medicine, General & Internal

Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer

Manish A. Shah et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.